Drugs News and Research

RSS

Secondhand smoke exposure reduces chemotherapy effectiveness in head and neck cancer patients

People who are diagnosed with head and neck cancer often receive a standard type of chemotherapy as part of their treatment.

27 Feb 2024

Bariatric surgery outperforms medical management in long-term diabetes control

People with type 2 diabetes who underwent bariatric surgery achieved much better long-term blood glucose control compared to people who received medical management plus lifestyle interventions, according to a new study published in JAMA, or Journal of the American Medical Association, and funded by the National institute of Diabetes, Digestive and Kidney Diseases, part of The National Institutes of Health.

27 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO Centers in Haiti.

27 Feb 2024

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Diabetic patients who take anti-diabetic drugs - known as glitazones - long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

26 Feb 2024

Revolutionary stem cell culture method produces full model of human central nervous system

The first stem cell culture method that produces a full model of the early stages of the human central nervous system has been developed by a team of engineers and biologists at the University of Michigan, the Weizmann Institute of Science, and the University of Pennsylvania.

26 Feb 2024

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses, capable of establishing lifelong latent infections in humans and causing various diseases.

26 Feb 2024

Horse sedative use among humans spreads in deadly mixture of ‘tranq’ and fentanyl

Andrew McClave Jr. loved to lift weights. The 6-foot-4-inch bartender resembled a bodybuilder and once posed for a photo flexing his muscles with former pro wrestler Hulk Hogan.

26 Feb 2024

California Gov. Newsom wants voters to approve billions more to help the homeless. Will it help?

California voters will decide March 5 whether to pump billions more dollars into combating the nation's worst homelessness crisis, an investment Democratic Gov. Gavin Newsom argues will finally provide the housing and treatment so badly needed by tens of thousands of homeless people.

26 Feb 2024

Mediterranean diet linked to lower depression risk in older women

A study in the British Journal of Nutrition finds that adherence to the Mediterranean diet is inversely associated with depressive symptoms, particularly in older women, highlighting the diet's potential mental health benefits.

25 Feb 2024

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA).

24 Feb 2024

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

23 Feb 2024

Research reveals bacteria's dynamic defense duo against phage viruses

Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.

23 Feb 2024

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Biomedical engineers at Duke University have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Pregnancy care was always lacking in jails. It could get worse.

It was about midnight in June 2022 when police officers showed up at Angela Collier's door and told her that someone anonymously requested a welfare check because they thought she might have had a miscarriage.

23 Feb 2024

Understanding how stress accelerates cancer spread

Stress is inevitable. But too much of it can be terrible for our health. Chronic stress can increase our risk for heart disease and strokes.

22 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Elevated IFN-γ levels linked to long COVID, study finds

Researchers find elevated IFN-γ levels in long COVID patients, with symptom improvement correlating with decreased IFN-γ, suggesting it as a potential biomarker and target for therapeutic intervention.

22 Feb 2024

New immunotherapy target activin receptor 1C shows promise against cancer

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Feb 2024

Drugs News and Research

Secondhand smoke exposure reduces chemotherapy effectiveness in head and neck cancer patients

Bariatric surgery outperforms medical management in long-term diabetes control

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Revolutionary stem cell culture method produces full model of human central nervous system

Structural study identifies target for broad-spectrum antivirals against herpesviruses

Horse sedative use among humans spreads in deadly mixture of ‘tranq’ and fentanyl

California Gov. Newsom wants voters to approve billions more to help the homeless. Will it help?

Mediterranean diet linked to lower depression risk in older women

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Research reveals bacteria's dynamic defense duo against phage viruses

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Pregnancy care was always lacking in jails. It could get worse.

Understanding how stress accelerates cancer spread

Natural killer cells lead the charge in cancer treatment innovation

Elevated IFN-γ levels linked to long COVID, study finds

New immunotherapy target activin receptor 1C shows promise against cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News